Phase II Trial of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma
Phase of Trial: Phase II
Latest Information Update: 10 Jun 2019
Price : $35 *
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Liposarcoma
- Focus Therapeutic Use
- 02 Apr 2018 Planned number of patients changed from 100 to 37.
- 27 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2019.
- 27 Apr 2017 Status changed from suspended to recruiting.